# OnCo record paper-jones-nrg1-fusions-recurrent-actionable-kras-wild-type-pdac-ccr-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-jones-nrg1-fusions-recurrent-actionable-kras-wild-type-pdac-ccr-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-jones-nrg1-fusions-recurrent-actionable-kras-wild-type-pdac-ccr-2019" ;
  schema:name "Jones 2019: NRG1 gene fusions are recurrent, clinically actionable rearrangements in KRAS wild-type pancreatic ductal adenocarcinoma"@en ;
  schema:description "In a Canadian programme sequencing the genomes of advanced pancreatic cancers in real time, tumours without a KRAS mutation repeatedly carried NRG1 fusions, and patients treated with HER-family blockers on the strength of that finding responded. It showed that fusion testing in KRAS wild-type disease changes treatment."@en ;
  schema:url <https://onco.cc/key-papers/paper-jones-nrg1-fusions-recurrent-actionable-kras-wild-type-pdac-ccr-2019/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-19-0191>, <https://pubmed.ncbi.nlm.nih.gov/31068372/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-19-0191> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Jones MR, Williamson LM, Topham JT, et al." ;
  onco:cancers <https://onco.cc/cancers/kras-wild-type-pdac/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/afatinib/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .